COMMUNIQUÉS West-GlobeNewswire
-
Better Choice Company Board of Directors Authorize Stock Repurchase Program
16/04/2024 -
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
16/04/2024 -
Kane Biotech to Host Investor Webinar
16/04/2024 -
Solera Health Expands its Curated Network to Help Payers and Employers Address High-Cost Cardiometabolic Disease
16/04/2024 -
Turnstone Biologics Appoints William Waddill to its Board of Directors
16/04/2024 -
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
16/04/2024 -
Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.
16/04/2024 -
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
16/04/2024 -
GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
16/04/2024 -
Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.
16/04/2024 -
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING
16/04/2024 -
Aphaia Pharma to Participate in a Panel Discussion at the 10th LSX World Congress
16/04/2024 -
Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting
16/04/2024 -
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting
16/04/2024 -
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
16/04/2024 -
Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path
16/04/2024 -
ProPhase Labs Unveils Project ZenQ-AI
16/04/2024 -
Excision BioTherapeutics Announces Oral Presentation of HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24 2024
16/04/2024 -
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
16/04/2024
Pages